Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bio Essence (BIOE) Cash & Current Investments (2020 - 2025)

Bio Essence has reported Cash & Current Investments over the past 6 years, most recently at $28741.0 for Q3 2025.

  • Quarterly results put Cash & Current Investments at $28741.0 for Q3 2025, down 9.67% from a year ago — trailing twelve months through Sep 2025 was $28741.0 (down 9.67% YoY), and the annual figure for FY2024 was $3371.0, up 2857.02%.
  • Cash & Current Investments for Q3 2025 was $28741.0 at Bio Essence, up from $2000.0 in the prior quarter.
  • Over the last five years, Cash & Current Investments for BIOE hit a ceiling of $31818.0 in Q3 2024 and a floor of $89.0 in Q3 2023.
  • Median Cash & Current Investments over the past 5 years was $1286.0 (2022), compared with a mean of $7171.1.
  • Biggest five-year swings in Cash & Current Investments: tumbled 98.53% in 2022 and later surged 35650.56% in 2024.
  • Bio Essence's Cash & Current Investments stood at $303.0 in 2021, then surged by 1966.67% to $6262.0 in 2022, then crashed by 98.18% to $114.0 in 2023, then skyrocketed by 2857.02% to $3371.0 in 2024, then soared by 752.6% to $28741.0 in 2025.
  • The last three reported values for Cash & Current Investments were $28741.0 (Q3 2025), $2000.0 (Q1 2025), and $3371.0 (Q4 2024) per Business Quant data.